HOTH
NASDAQ
US
Hoth Therapeutics, Inc. - Common Stock
$0.56
▲ +$0.02
(+2.74%)
Vol 1.0M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$15.4M
ROE
-133.7%
D/E
0.00
Beta
0.44
52W
$1–$4
Wall Street Consensus
7 analysts · Apr 20262
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 20.0%
Next Report
May 11, 2026
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | — | — | — |
| Dec 2025 | $-0.10 | $-0.16 | $-0.06 |
| Sep 2025 | $-0.10 | $-0.30 | $-0.20 |
| Jun 2025 | $-0.14 | $-0.17 | $-0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -$2.2M | -$2.4M | -$3.5M | -$2.2M | -$4.1M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -114.3% | -112.9% | -114.3% | -114.3% | -114.3% | -133.7% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 27.57 | 27.78 | 27.57 | 27.57 | 27.57 | 8.81 |
Key Ratios
ROA (TTM)
-123.4%
P/B
0.8
EPS (TTM)
$-1.06
52W High
$3.80
52W Low
$0.66
$0.66
52-Week Range
$3.80
Financial Health
Free Cash Flow
-$2.8M
Net Debt
-$7.8M
Cash
$7.8M
Total Debt
$14K
As of Sep 30, 2025
How does HOTH compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
HOTH valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.8
▼
65%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
HOTH profitability vs Pharmaceuticals peers
ROE
-133.7%
▼
146%
below
peers
(-54.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-123.4%
▼
230%
below
peers
(-37.4%)
vs Peers
vs Industry
Weak
HOTH financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
8.8
▲
162%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.4
▼
53%
below
peers
(0.9)
vs Peers
vs Industry
More volatile
HOTH fundamentals radar
HOTH
Peer median
Industry
HOTH profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HOTH vs peers: key metrics
Top Holders
Top 5: 5.03%DRW Securities, LLC
1.67%
$200K
Vanguard Group Inc
1.38%
$165K
Geode Capital Management, L…
1.17%
$139K
State Street Corporation
0.41%
$49K
Susquehanna International G…
0.40%
$48K
As of Dec 31, 2025
Latest News
No related news yet